ID: ALA4645663

Max Phase: Preclinical

Molecular Formula: C8H5Cl3O3S

Molecular Weight: 287.55

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C=CS(=O)(=O)Oc1c(Cl)cc(Cl)cc1Cl

Standard InChI:  InChI=1S/C8H5Cl3O3S/c1-2-15(12,13)14-8-6(10)3-5(9)4-7(8)11/h2-4H,1H2

Standard InChI Key:  AWYDFZVRVMSJEE-UHFFFAOYSA-N

Associated Targets(Human)

Histone-lysine N-methyltransferase SETD7 390 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 287.55Molecular Weight (Monoisotopic): 285.9025AlogP: 3.50#Rotatable Bonds: 3
Polar Surface Area: 43.37Molecular Species: HBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.62CX LogD: 3.62
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.80Np Likeness Score: -0.67

References

1. Hou Z, Min W, Zhang R, Niu A, Li Y, Cao L, Han J, Luo C, Yang P, Ding H..  (2020)  Lead discovery, chemical optimization, and biological evaluation studies of novel histone methyltransferase SET7 small-molecule inhibitors.,  30  (9): [PMID:32173197] [10.1016/j.bmcl.2020.127061]

Source